0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brain Cancer Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Gliosarcoma Global Market Report 2025 - Product Thumbnail Image

Gliosarcoma Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Glioblastoma Multiforme Global Market Report 2025 - Product Thumbnail Image

Glioblastoma Multiforme Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$3,850USDGBP
EUR$4,850USDGBP
From
EUR$3,850USDGBP
EUR$4,850USDGBP
From
EUR$4,900USDGBP
Brain Cancer Diagnostics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Brain Cancer Diagnostics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Brain Metastasis - Pipeline Insight, 2025 - Product Thumbnail Image

Brain Metastasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Thymoma - Pipeline Insight, 2025 - Product Thumbnail Image

Thymoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
Brain Metastases- Pipeline Insight, 2025 - Product Thumbnail Image

Brain Metastases- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 220 Pages
  • Global
From
EUR$2,500USDGBP
Malignant Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Glioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Meningioma - Pipeline Insight, 2025 - Product Thumbnail Image

Meningioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
Brain Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Brain Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Gliosarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Gliosarcoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Pediatric Brain Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Pediatric Brain Tumors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Leptomeningeal Metastases - Pipeline Insight, 2025 - Product Thumbnail Image

Leptomeningeal Metastases - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Astrocytoma - Pipeline Insight, 2025 - Product Thumbnail Image

Astrocytoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Ependymoma - Pipeline Insight, 2025 - Product Thumbnail Image

Ependymoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
From
EUR$2,999USDGBP
Glioblastoma Treatment Drugs - Global Strategic Business Report - Product Thumbnail Image

Glioblastoma Treatment Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 287 Pages
  • Global
From
EUR$5,850USDGBP
Loading Indicator

The Brain Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat brain cancer. Brain cancer is a type of cancer that affects the cells of the brain and can be caused by a variety of factors, including genetics, environmental exposure, and lifestyle. Brain cancer drugs are used to treat the symptoms of brain cancer, such as headaches, seizures, and nausea, as well as to slow the progression of the disease. Brain cancer drugs are typically divided into two categories: chemotherapy and targeted therapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific cancer cells and stop them from growing. Both types of drugs are used in combination to treat brain cancer. Some of the major companies in the Brain Cancer Drugs market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. These companies are involved in the development and sale of drugs used to treat brain cancer, as well as in the research and development of new treatments. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more